Merck & Co., Inc.
MRK
$87.37
$1.291.50%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.85% | 6.66% | 405.30% | -33.47% | 191.30% |
| Total Depreciation and Amortization | -0.19% | 15.13% | 23.37% | 17.18% | 21.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -52.34% | -90.52% | 5.41% | 1,414.75% | -98.77% |
| Change in Net Operating Assets | -123.22% | -9.76% | -1,388.19% | 18.60% | 38.14% |
| Cash from Operations | -41.58% | -19.09% | 1,302.44% | 20.40% | 52.19% |
| Capital Expenditure | 3.41% | -54.24% | 5.26% | 13.19% | 18.03% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 97.84% | -168.83% | -148.46% | -50.18% | -222.47% |
| Cash from Investing | 27.97% | -8.07% | -2,824.53% | -1,051.20% | 90.66% |
| Total Debt Issued | -98.67% | -- | -- | 99.95% | -54.33% |
| Total Debt Repaid | -- | -232.89% | -17,866.67% | 100.00% | 100.00% |
| Issuance of Common Stock | -83.56% | -78.16% | 100.00% | -28.57% | -10.98% |
| Repurchase of Common Stock | -435.86% | -854.10% | -24.43% | 4.72% | 25.74% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.58% | -5.13% | -5.35% | -5.28% | -5.36% |
| Other Financing Activities | 11.82% | 23.08% | -1,300.00% | -220.00% | 5.98% |
| Cash from Financing | -392.43% | -104.51% | -34.03% | 43.20% | -67.64% |
| Foreign Exchange rate Adjustments | 556.10% | 213.04% | -297.31% | 287.26% | 11.83% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -111.56% | -270.44% | 22.16% | 12.11% | 239.96% |